Glossary of agricultural & food system terms | HESTIA

Browse the 409,595 standardised terms HESTIA uses to describe the agri-food system — crops, emissions, inputs, practices and regions. Free and open.

!Karas
!Kheis
'Abdin
'Ain Schams
'Ataqah
'Ayn al-'Arab
'Eua
's-Gravendeel
's-Gravenhage
's-Gravenzande
's-Hertogenbosch
(+)-2-Carene (1S,6R)-3,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; 2-Carene; (+)-2-Carene; 4497-92-1; 554-61-0; IBVJWOMJGCHRRW-UHFFFAOYSA-N; Bicyclo[4.1.0]hept-2-ene, 3,7,7-trimethyl-; 4,7,7-trimethylbicyclo[4.1.0]hept-4-ene; ACMC-1BNB4; CHEMBL2286984; CTK4I8566; DTXSID00858821; Bicyclo[4.1.0]hept-2-ene, 3,7,7-trimethyl-, (1S-cis)-; MFCD00001314; AKOS025295339; DB-070610; TC-173076; 3,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; Bicyclo[4.1.0]hept-2-ene,3,7,7-trimethyl-, (1S,6R)-; (1S,6R)-3,7,7-TRIMETHYLBICYCLO[4.1.0]HEPT-2-ENE; 2-Carene, (+)-; EINECS 224-792-4
(+)-3-Carene (1S,6R)-3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene; (+)-3-Carene; 498-15-7; Isodiprene; (+)-delta3-Carene; (1S,6R)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene; (+)-car-3-ene; UNII-XBL40A7IA6; (1S)-(+)-3-Carene; XBL40A7IA6; (1R,6S)-4,7,7-trimethylbicyclo[4.1.0]hept-3-ene; Bicyclo[4.1.0]hept-3-ene, 3,7,7-trimethyl-, (1S,6R)-; (S)-(+)-3-Carene; (1S)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene; (+)-alpha-carene; .delta. 3-carene; 3-.delta.-Carene; Car-3-ene; 1352058-87-7; .DELTA.-caR-3-ene; (+)-Delta(3)-carene; (1S)-3,7,7-Trimethylbicyclo(4.1.0)hept-3-ene; 4,7,7-Trimethyl-3-norcarene; 3-Carene, (+)-; (1S,6R)-(+)-3-carene; 3-Norcarene, 3,7,7-trimethyl-; Bicyclo(4.1.0)hept-3-ene, 3,7,7-trimethyl-, (1S,6R)-; EINECS 207-856-6; .delta.-3-Carene; CHEBI:7; 1alpha,6alpha-car-3-ene; (1S,6R)-3-Carene; Bicyclo(4.1.0)hept-3-ene, 3,7,7-trimethyl-, (1S)-; DTXSID60858827; BQOFWKZOCNGFEC-BDAKNGLRSA-N; ZINC967794; (+)-3-Carene, analytical standard; 3,7,7-trimethyl bicyclohept-3-ene; 3-Carene, (1S,6R)-(+)-; (1S)-(+)-3-Carene, 99%; LMPR0102120021; AS-67519; FT-0651899; (+)-3-Carene 1000 microg/mL in Isopropanol; C11382; A827862; J-511415; Q15222640; UNII-H2M15SNR6N component BQOFWKZOCNGFEC-BDAKNGLRSA-N; (+)-3-delta-Carene, primary pharmaceutical reference standard; 3-Carene, (+)-; EINECS 207-856-6
(+)-Aromadendrene (1aR,4aR,7R,7aR,7bS)-Decahydro-1,1,7-trimethyl-4-methylene-1H-cycloprop[e]azulene; (1AR-(1aalpha,4aalpha,7alpha,7abeta,7balpha))-decahydro-1,1,7-trimethyl-4-methylene-1H-cycloprop(e)azulene; EINECS 207-694-6
(+)-Borneol (1R,2S,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; (+)-Borneol; Borneol; 464-43-7; Isoborneol; 507-70-0; d-Borneol; UNII-8D24LWT4FK; FEMA No. 2157; DL-Isoborneol; DL-Borneol; 8D24LWT4FK; (1R,2S,4R)-rel-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; Borneocamphor; Camphol; Baros camphor; Borneo camphor; Bornyl alcohol; Malayan camphor; Sumatra camphor; trans-Borneol; Bhimsaim camphor; 2-Hydroxybornane; 2-Camphanol; CHEBI:15393; 2-Hydroxycamphane; (1R,2S,4R)-Borneol; Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, (1R,2S,4R)-; Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, (1R,2S,4R)-rel-; Dryobalanops camphor; 2-Bornanol, endo-; (1R,2S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; 2-endo-Bornyl alcohol; Camphane, 2-hydroxy-; CCRIS 6550; CCRIS 7300; HSDB 946; 124-76-5; EINECS 207-352-6; EINECS 208-080-0; UN1312; BRN 2038056; AI3-00116; 2-Hydroxy-1,7,7-trimethylnorbornane, endo-; Borneol, (+)-; 1,7,7-Trimethyl-bicyclo(2.2.1)heptan-2-ol, endo-; (1R-endo)-1,7,7-Trimethylbicyclo(2.2.1)heptan-2-ol; endo-(1R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; BICYCLO(2.2.1)HEPTAN-2-OL, 1,7,7-TRIMETHYL-, endo-; Bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, (1R,2S,4R)-rel-; MFCD00074821; NSC-60223; (-) Borneol; (+)-Borneol, 97%; (1R-endo)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; SCHEMBL56713; 4-06-00-00281 (Beilstein Handbook Reference); CHEMBL486208; GTPL6413; DTXSID2058700; BDBM36265; HY-N1368A; (+)-Borneol, analytical standard; ZINC968100; Bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, (1R-endo)- (9CI); CCG-36088; AKOS016004136; CS-7758; Borneol [UN1312] [Flammable solid]; A14485; 464B437; Q412435; Q-100570; F0001-1255; (1R,4R,6S)-1,7,7-trimethylbicyclo[2.2.1]heptan-6-ol; UNII-M89NIB437X component DTGKSKDOIYIVQL-WEDXCCLWSA-N; Bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, endo- (9CI); Borneol, (+)-; 4-06-00-00281 (Beilstein Handbook Reference)
(+)-Diacetyl-L-tartaric anhydride (3R-trans)-3,4-Bis(acetyloxy)dihydro-2,5-furandione; O,O-Diacetyl tartaric acid anhydride; EINECS 228-502-7
(+)-Fenchone (1S,4R)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one; (+)-1,3,3-Trimethyl-2-norbornanone; (+)-Fenchone; (+)-Fenchone, 98%; (1S)-(+)-fenchone; 1,3,3-Trimethyl-2-norbornanone, D-; 1,3,3-Trimethyl-2-norcamphanone, D-; 2-Norbornanone, 1,3,3-trimethyl-, (1R,4S)-(+)-; 2-Norbornanone, 1,3,3-trimethyl-, (1S,4R)-(+)-; 225-160-0; 4695-62-9; d-1,3,3-Trimethyl-2-norbornanone; d-1,3,3-Trimethyl-2-norcamphanone; D-FENCHONE, 77%; EINECS 225-160-0; FEMA No. 2479; fenchone, (1S)-isomer; Fenchone, D-; D-FENCHONE; (1S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one; UNII-S436YKU51N; (1S)-fenchone; (+)-2-fenchanone; (1S,4R)-fenchone; (+)-fenchan-2-one; (1S,4R)-2-fenchanone; (1S,4R)-fenchan-2-one; (1S,4R)-(+)-fenchone; S436YKU51N; Bicyclo[2.2.1]heptan-2-one, 1,3,3-trimethyl-, (1S,4R)-; (1S,4R)-(+)-2-fenchanone; (1S,4R)-(+)-fenchan-2-one; 2-Fenchanone, D-; d-Fenchone (natural); D(+)-Fenchone, 97%; (1S)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one; 1,3,3-Trimethylbicyclo(2.2.1)heptan-2-one, (1S)-; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1S)-; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1S,4R)-; (1s)-1,3,3-trimethyl-norbornan-2-one; (1S)-1,3,3-Trimethylbicyclo(2.2.1)heptan-2-one; CHEBI:165; SCHEMBL856607; DTXSID60858862; LHXDLQBQYFFVNW-XCBNKYQSSA-N; ZINC967571; (+)-Fenchone, analytical standard; MFCD00070689; AKOS015903221; MCULE-2746796380; NE11172; Q27067421; (+)-Fenchone, primary pharmaceutical reference standard; (+)-Fenchone, purum, >=98.0% (sum of enantiomers, GC); (1S)-(+)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one; Bicyclo[2.2.1]heptan-2-one,1,3,3-trimethyl-,(1S,4R)-; UNII-4Q6W8568TG component LHXDLQBQYFFVNW-XCBNKYQSSA-N; D-Fenchone; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1S)-
(+)-Flutriafol (alphaS)-alpha-(2-Fluorophenyl)-alpha-(4-fluorophenyl)-1H-1,2,4-triazole-1-ethanol; Flutriafol, (+)-; UNII-4W0XEF5702
(+)-Isomenthol (1S,2R,5R)-5-Methyl-2-(1-methylethyl)-cyclohexanol; Isomenthol, (+)-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1S-(1alpha,2beta,5beta))-
(+)-Linalool (3S)-3,7-Dimethyl-1,6-octadien-3-ol; (+)-Linalool; d-linalool; (S)-linalool; (3S)-Linalool; 126-90-9; (S)-(+)-Linalool; (3S)-3,7-dimethylocta-1,6-dien-3-ol; (S)-3,7-Dimethyl-1,6-octadien-3-ol; UNII-F4VNO44C09; (S)-Linalol; coriandrol; F4VNO44C09; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; (3S)-3,7-dimethyl-1,6-octadien-3-ol; L-Linalool; (R)-linalool; LINALOOL (+); 1,6-Octadien-3-ol, 3,7-dimethyl-, (S)-; Licareol; linalool terpenes; (R)-linalol; (-)-3,7-dimethyl-1,6-octadien-3-ol; (3R)-3,7-dimethyl-1,6-octadien-3-ol; EINECS 204-810-7; r-(-)-linalool; (+)-b-Linalool; (-)-R-linalool; (+)-S-Linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; CHEBI:98; SCHEMBL254425; DTXSID40883319; CDOSHBSSFJOMGT-SNVBAGLBSA-N; ZINC1529819; N2418; 1,6-Octadien-3-ol,3,7-dimethyl-, (3S)-; A14858; C11389; Q27105233; UNII-D81QY6I88E component CDOSHBSSFJOMGT-SNVBAGLBSA-N; D-Linalool; EINECS 204-810-7
(+)-Longifolene [1S-(1 alpha, 3a beta, 4 alpha, 8a beta)]-Decahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene; Longifolene; EINECS 207-491-2
(+)-Menthol (1S,2R,5S)-5-Methyl-2-(1-methylethyl)-cyclohexanol; Menthol, (+)-; EINECS 239-387-8
(+)-Neomenthol (1S,2S,5R)-5-Methyl-2-(1-methylethyl)-cyclohexanol; Neomenthol, (+)-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1S-(1alpha,2alpha,5beta))-
(+)-Nicotine 3-[(2R)-1-Methyl-2-pyrrolidinyl]pyridine; Nicotine, (+)-; 5-23-06-00064 (Beilstein Handbook Reference)
(+)-Profenofos Phosphorothioic acid, [P(S)]-O-(4-Bromo-2-chlorophenyl) O-ethyl S-propyl ester; Phosphorothioic acid, O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl ester, (S)-; BRN 2150258
(+)-Tetraconazole 1-[(2R)-2-(2,4-Dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-1H-1,2,4-triazole; (+)-Tetraconazole; R-(+)-Tetraconazole; UNII-9225R3CLW5; 131320-41-7; 9225R3CLW5; Rectusazole; Tetraconazole, (+)-; (R)-tetraconazole; (R)-(+)-Tetraconazole; CHEBI:84000; ZINC5784668; 1H-1,2,4-Triazole, 1-((2R)-2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl)-; Q27157378; UNII-8FGY868T0G component LQDARGUHUSPFNL-MRVPVSSYSA-N; 1-[(2R)-2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-1H-1,2,4-triazole; Tetraconazole, (+)-; UNII-9225R3CLW5
(+)-Verbenone (1R,5R)-4,6,6-Trimethylbicyclo [3.1.1]hept-3-en-2-one; d-Verbenone; 4-07-00-00327 (Beilstein Handbook Reference)
(+)-alpha-Pinene (1R,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; (+)-alpha-Pinene; 7785-70-8; (1R,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; (1R)-(+)-alpha-Pinene; (1R,5R)-alpha-pinene; UNII-H6CM4TWH1W; H6CM4TWH1W; Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, (1R,5R)-; CHEBI:28261; (+)-Pin-2(3)-ene; MFCD00001346; (+)-3,6,6-TRIMETHYLBICYCLO[3.1.1]HEPT-2-ENE; (1R,5R)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene; Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl-, (1R,5R)-; alpha-Pinene(dextro); 1R-(+)-a-pinene; (+)-2-Pinene; (1R)-(+)-alpha-Pinene, 98%, 80% ee; (1S)-(-)-alpha-Pinene; alpha-Pinene, (+)-; (1R,5R)-2-Pinene; CCRIS 9059; l-Pinen; EINECS 232-087-8; alpha-Pinene, 98%; (+)--Pinene; PubChem18155; (+)-.alpha.-Pinene; EC 232-087-8; (1R,5R)-pin-2-ene; DSSTox_CID_21671; DSSTox_RID_79811; DSSTox_GSID_41671; (+)-alpha-Pinene, 98%; KSC918A0J; CHEMBL1236329; DTXSID7041671; (+)-alpha-Pinene, >=99%; CTK8B8004; (+)-(1R,5R)-|A-pinene; GRWFGVWFFZKLTI-RKDXNWHRSA-N; ZINC967579; Tox21_303429; 2203AC; ANW-59110; AKOS016842885; (+)-alpha-Pinene, analytical standard; EBD2198276; LMPR0102120012; NE10091; RTR-024907; NCGC00257486-01; (1R)-(+)-alpha-Pinene, 97%, FG; AS-35304; BC000911; SC-23004; CAS-7785-70-8; ST2414095; 4,7,7-trimethylbicyclo[3.1.1]hept-3-ene; C06306; 785P264; A839247; Q-101284; Q2095629; (1S,5S)-4,7,7-trimethylbicyclo[3.1.1]hept-3-ene; alpha-Pinene, primary pharmaceutical reference standard; UNII-996299PUKB component GRWFGVWFFZKLTI-RKDXNWHRSA-N; UNII-JPF3YI7O34 component GRWFGVWFFZKLTI-RKDXNWHRSA-N; Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl-, (1theta)-; alpha-Pinene, (+)-; EINECS 232-087-8
(+)-alpha-Terpineol (1R)-alpha,alpha,4-Trimethyl-3-cyclohexene-1-methanol; (+)-alpha-Terpineol; (R)-(+)-alpha-Terpineol; 7785-53-7; (R)-p-Menth-1-en-8-ol; (R)-alpha-terpineol; (+)-p-menth-1-en-8-ol; (R)-2-(4-Methyl-3-cyclohexenyl)isopropanol; WUOACPNHFRMFPN-VIFPVBQESA-N; 2-[(1R)-4-methylcyclohex-3-en-1-yl]propan-2-ol; alpha-Terpinenol; 1-alpha-terpineol; Menth-1-en-8-ol; L-alpha-TERPINEOL; (S)-(-)-alpha-terpineol; (R)-alpha,alpha,4-Trimethylcyclohex-3-ene-1-methanol; 3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-, (1R)-; alpha-Terpinol; alpha-terpineole; Lily of valley; .alpha.-Terpinol; Terpineol, .alpha.; dl-.alpha.-Terpineol; 8-Hydroxy-p-menth-1-ene; 3-Cyclohexene-1-methanol, .alpha.,.alpha.4-trimethyl-; (+)-(4R)-alpha-terpineol; CHEBI:300; SCHEMBL891812; (4R)-p-menth-1-en-8-ol; (6R)-p-menth-1-en-8-ol; (.+/-.)-.alpha.-Terpineol; DTXSID60884429; ZINC967799; MFCD00171435; LMPR0102090028; (+)-alpha-Terpineol, analytical standard; 4-(2-Hydroxy-2-propyl)-1-methylcyclohexene; FT-0772029; 2-(4-Methyl-3-cyclohexen-1-yl)-2-propanol; (R)-2-(4-methylcyclohex-3-enyl)propan-2-ol; (R)-a,a,4-trimethylcyclohex-3-ene-1-methanol; C09902; 2-(4-Methyl-3-cyclohexen-1-yl)-2-propanol #; .alpha.,.alpha.,4-Trimethyl-3-Cyclohexene-1-methanol; alpha,alpha,4-Trimethyl-(S)-3-Cyclohexene-1-methanol; Q27105290; (1R)-alpha,alpha,4-trimethyl-3-cyclohexene-1-methanol; alpha,alpha,4-Trimethyl-(1S)-3-Cyclohexene-1-methanol; 2-(4-methylcyclohex-3-enyl)propan-2-ol (alpha-terpineol); UNII-21334LVV8W component WUOACPNHFRMFPN-VIFPVBQESA-N; UNII-R53Q4ZWC99 component WUOACPNHFRMFPN-VIFPVBQESA-N; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-, (theta)-; EINECS 232-081-5
(+)-beta-Hexabromocyclododecane (1R,2S,5R,6S,9S,10S)-1,2,5,6,9,10-Hexabromocyclododecane; beta-Hexabromocyclododecane, (+)-; UNII-5JE712TFO8
(+)-beta-Pinene (1R,5R)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane; (+)-beta-Pinene; 19902-08-0; beta-Pinene, (+)-; UNII-IGO73S04D5; IGO73S04D5; CHEBI:50026; (1R,5R)-pin-2(10)-ene; (1R,5R)-6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane; Nopinen; (1R,5R)-6,6-Dimethyl-2-methylenebicyclo(3.1.1)heptane; (1R,5R)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane; D-beta-Pinene; beta-Pinene-(+); (1S)-(1)-beta-Pinene; (1R)-(+)-beta-Pinene; (+)-2(10)-Pinene; FEMA No. 2903, (+)-; (1R,5R)-beta-pinene; 2(10)-Pinene, (1R,5R)-(+)-; CHEMBL2269085; CTK8F1479; KS-00000VRK; DTXSID00173682; WTARULDDTDQWMU-RKDXNWHRSA-N; Bicyclo(3.1.1)heptane, 6,6-dimethyl-2-methylene-, (1R)-; ZINC967582; (+)-beta-Pinene, analytical standard; AKOS025311429; (1R,5R)-6,6-dimethyl-2-methylene-norpinane; C20244; 6,6-dimethyl-2-methylenebicyclo[3.1.1]-heptane; J-500364; Q27121761; (1R,5R)-6,6-dimethyl-2-methylene-bicyclo[3.1.1]Heptane; UNII-4MS8VHZ1HJ component WTARULDDTDQWMU-RKDXNWHRSA-N; UNII-996299PUKB component WTARULDDTDQWMU-RKDXNWHRSA-N; (1R,5R)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]hept-2-ene; Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1R,5R)-; beta-Pinene, (+)-; UNII-IGO73S04D5
(+)-cis-(S)-Allethrin (1R,3S)-rel-2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester; Allethrin, cis-(+/-)-; 2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate
(+)-cis-Permethrin (1R,3R)-3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid (3-phenoxyphenyl)methyl ester; Permethrin, (+)-cis-; AI3-29264
(+)-cis-Tetramethrin (1R-cis)-2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl ester; Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl ester, (1R-cis)-; EINECS 257-144-4
(+)-trans-Chrysanthemic acid (1R,3R)-2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid; Chrysanthemic acid d-trans-form; 4-09-00-00169 (Beilstein Handbook Reference)
(+-)-2-Hydroxy-N-(1,1,3,3-tetramethylbutyl)propanamide
(+-)-3-Butyn-2-ol
(+-)-6-((2-Methylpiperidino)methyl)-5-indanol maleate 2,3-Dihydro-6-[(2-methyl-1-piperidinyl)methyl]-1H-inden-5-ol (2Z)-2-butenedioate (salt); 5-Indanol, 6-((2-methylpiperidino)methyl)-, maleate, (+-)-; 1H-Inden-5-ol, 2,3-dihydro-6-((2-methyl-1-piperidinyl)methyl)-, (Z)-2-butenedioate, (+-)-
(+/-)-Dimethylbusulphan (R*,R*)-(+-)-2,5-Hexanediol, Dimethanesulfonate; 2,5-Hexanediol, dimethanesulfonate, (+-)-; (+/-)-Dimethylbusulfan
(+/-)-Muscarine chloride (+/-)-Chloride muscarine; 2-Furanmethanaminium, tetrahydro-4-hydroxy-N,N,N,5-tetramethyl-, chloride, (2alpha,4beta,5alpha)-(+-)-; (+-)-Muscarine chloride
(-)-Abscisic acid (2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic acid; Abscisic acid, (-)-(2Z,4E)-; UNII-4F7961S98F
(-)-Anabasine 3-(2S)-2-Piperidinylpyridine; Anabasine; 494-52-0; (-)-Anabasine; (S)-3-(Piperidin-2-yl)pyridine; Neonikotin; Anabasin; Neonicotine; Anabazin; L-3-(2'-Piperidyl)pyridine; S-(-)-Anabasine; (S)-anabasine; 3-[(2S)-piperidin-2-yl]pyridine; L-(-)-Anabasine; Piperidine, 2-(3-pyridyl)-; Pyridine, 3-(2-piperidyl)-; UNII-LMS11II2LO; (-)-2-(3'-Pyridyl)piperidine; Pyridine, 3-(2S)-2-piperidinyl-; NSC 87504; LMS11II2LO; CHEBI:74; MTXSIJUGVMTTMU-JTQLQIEISA-N; 2-(3'-Pyridyl) piperidine; Pyridine, 3-(2-piperidinyl)-, (S)-; Caswell No. 051; CAS-494-52-0; HSDB 3462; EINECS 207-791-3; Pyridine, 3-(2-pyridyl) piperidine; EPA Pesticide Chemical Code 006001; BRN 0082637; (S)-(-)-Anabasine; MLS000737148; 2-(3-Pyridinyl)piperidine #; L(-)-Anabasine; Tocris-1971; DSSTox_CID_21607; DSSTox_RID_79783; DSSTox_GSID_41607; 5-23-06-00096 (Beilstein Handbook Reference); SCHEMBL3465120; 3-(2S)-2-Piperidinylpyridine; WLN: T6NJ C- BT6MTJ; CHEMBL1526229; DTXSID9041607; ZINC31165; US8609708, 59 Anabasine; BDBM109767; HY-B1532; KS-00000FY0; NSC87504; Tox21_301952; 6694AB; MFCD00871391; NSC-87504; AKOS000277110; AB07621; Piperidine, 2-(3-pyridyl)- (8CI); NCGC00016468-01; NCGC00025333-01; NCGC00255520-01; AS-55183; TS-01458; CS-0013343; FT-0613586; 3-[(2S)-Piperidin-2-yl]pyridine (Anabasine); C11357; Pyridine, 3-(2-piperidinyl)-, (S)- (9CI); 494A520; (2S)-1,2,3,4,5,6-hexahydro-2,3'-bipyridinyl; BRD-K94837957-003-01-4; Anabasine; 5-23-06-00096 (Beilstein Handbook Reference)
(-)-Borneol (1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; (-)-Borneol; 464-45-9; Borneol; L-Borneol; (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; endo-Borneol; Linderol; [(1s)-endo]-(-)-borneol; UNII-1Y84986J9Q; Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, (1S,2R,4S)-; 507-70-0; Borneo camphor; Bornyl alcohol; Sumatra camphor; CHEBI:15394; DL-Borneol; NGAI camphor; 1-Bornyl alcohol; l-2-Camphanol; l-2-Bornanol; L(-)-Borneol; MFCD00003759; 1Y84986J9Q; (1S-endo)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; DSSTox_CID_2035; L(-)-Borneol, 97%; DSSTox_RID_76465; DSSTox_GSID_22035; d-Borneol; endo-(1S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; endo-2-Bornanol; Bicyclo(2.2.1)heptan-2-ol, 1,7,7-trimethyl-, (1S,2R,4S)-; EINECS 207-353-1; Borneol, (1S,2R,4S)-(-)-; CAS-464-45-9; (1R,2S,4R)-Borneol; (1S-endo)-1,7,7-Trimethylbicyclo(2.2.1)heptan-2-ol; (1R,2S,4R)-(+)-Borneol; (1S,2R,4S)-(-)-Borneol; NCGC00167417-01; Borneol (8CI); (+)-Bornyl alcohol; Borneol, (-)-; (1S,2R,4S)-borneol; Endo-(-)-Bornan-2-ol; (-)-Borneol, 99%; (1R-endo)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; (1S,2R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; endo-(1R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; SCHEMBL839194; CHEMBL3186705; DTXSID3022035; BDBM36266; HY-N1368B; (-)-Borneol, analytical standard; DTGKSKDOIYIVQL-QXFUBDJGSA-N; FEMA 2157?; ZINC967533; Tox21_112422; Tox21_302285; 9120AF; s3977; AKOS026745399; CS-7797; MCULE-4351689127; NE10277; (-)-Borneol, predominantly endo, 97%; NCGC00255110-01; endo-2-Hydroxy-1,7,7-trimethylnorbornane; 1,7,7-Trimethyl-endo-Bicyclo[2.2.1]heptan-2-ol; Q27089413; Borneol (20% Isoborneol) 1000 microg/mL in Methanol; F0001-2352; Z1705831809; (1S,3R,4S)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-ol; UNII-M89NIB437X component DTGKSKDOIYIVQL-QXFUBDJGSA-N; 1,7,7-Trimethyl-(1R,2S,4R)-rel-Bicyclo[2.2.1]heptan-2-ol; Rel-(1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; Borneol, (-)-; l-2-Bornanol
(-)-Bornyl acetate (1S,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol 2-acetate; Bornyl acetate, (-)-; (-)-Bornyl acetate
(-)-Camphor (1S)-1,7,7-Trimethyl-bicyclo[2.1.1]heptan-2-one; Camphor, (-)-; (-)-Alcanfor
(-)-Carvone (5R)-2-Methyl-5-(1-methylethenyl)-2-cyclohexen-1-one; (-)-Carvone; 6485-40-1; l-Carvone; (R)-(-)-Carvone; (R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-enone; (4R)-Carvone; Levo-carvone; R-(-)-Carvone; L(-)-Carvone; (-)-(R)-Carvone; 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, (5R)-; (-)-p-Mentha-6,8-dien-2-one; l-p-Mentha-1(6),8-dien-2-one; UNII-5TO7X34D3D; (R)-2-Methyl-5-(1-methylethenyl)-2-cyclohexen-1-one; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; CHEBI:15400; l-1-Methyl-4-isopropenyl-6-cyclohexen-2-one; (-)-(4R)-carvone; (R)-Carvone; MFCD00001578; Carvol; 5TO7X34D3D; ULDHMXUKGWMISQ-SECBINFHSA-N; l-Carvone (natural); (R)-(-)-p-Mentha-6,8-dien-2-one; (R)-5-Isopropenyl-2-methyl-2-cyclohexenone; (R)-5-isopropenyl-2-methylcyclohex-2-en-1-one; L(-)-Carvone, 99%; W-104816; (5R)-2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-one; laevo-carvone; EINECS 229-352-5; p-Mentha-6,8-dien-2-one, (-)-; AI3-36200; Carvone, (-)-; r-carvone; 07V; AK114181; 5-isopropenyl-2-methylcyclohex-2-en-1-one; (+) Carvone; bmse000500; Epitope ID:141509; EC 229-352-5; DSSTox_CID_21413; DSSTox_RID_79720; DSSTox_GSID_41413; (5R)-5-isopropenyl-2-methyl-cyclohex-2-en-1-one; 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, (theta)-; SCHEMBL230994; CHEMBL2229268; DTXSID7041413; CTK8F1396; (R)-(-)-Carvone, 98%; L-Carvone, natural, 99%, FG; (-)-Carvone, analytical standard; (R)-p-mentha-6,8-dien-2-one; BB_NC-01762; KS-00000V0T; L-Carvone, >=97%, FCC, FG; Tox21_300931; FCH920052; p-?Mentha-?6,8-?dien-?2-?one; ZINC14588455; AKOS006343214; LMPR0102090007; MCULE-7452592467; (4R)-p-mentha-1(6),8-dien-2-one; NCGC00248214-01; NCGC00254833-01; AC-13342; K048; CAS-6485-40-1; FT-0605067; ST24035374; C01767; (R)-(-)-5-Isopropenyl-2-methyl-2-cyclohexenone; (-)-Carvone, primary pharmaceutical reference standard; (R)?-?5-?Isopropenyl-?2-?methyl-?2-?cyclohexenone; Q27089417; UNII-75GK9XIA8I component ULDHMXUKGWMISQ-SECBINFHSA-N; 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, (R)- (9CI); Carvone, (-)-; AI3-36200
(-)-Cinchonidine Cinchonidine; CINCHONIDINE; (-)-Cinchonidine; 485-71-2; Cinchovatine; L-Cinchonidine; (8S,9R)-Cinchonidine; alpha-Quinidine; UNII-1U622LRA8Z; Cinchonan-9-ol, (8a,9R)-; TCMDC-123934; (8S,9R)-cinchonan-9-ol; (8alpha,9R)-Cinchonan-9-ol; 1U622LRA8Z; CHEBI:3703; (8-alpha,9R)-Cinchonan-9-ol; Cinchonan-9-ol, (8.alpha.,9R)-; (8alpha,9R)Cinchonan-9-ol; NSC 5364; 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; EINECS 207-622-3; MFCD00006783; (R)-[(4S,5S,7S)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-quinolin-4-ylmethanol; AI3-15317; SR-05000001575; Cinchonan-9-ol, (8alpha,9R)-; Cinchonan-9-ol, (8a alpha,9R)-; (-)cinchonidine; (-) cinchonidine; Cinchonidine,(S); Prestwick_66; Cinchonidine, 96%; PubChem7953; Spectrum_001165; Prestwick3_000606; Spectrum2_000719; Spectrum3_001745; Spectrum4_001173; Spectrum5_002073; BSPBio_000512; BSPBio_003450; KBioGR_001805; KBioSS_001645; MLS002153905; DivK1c_000501; SCHEMBL159532; SPECTRUM1500839; SPBio_000937; BPBio1_000564; CHEMBL533841; HMS501J03; KBio1_000501; KBio2_001645; KBio2_004213; KBio2_006781; KBio3_002670; DTXSID60883396; KMPWYEUPVWOPIM-KODHJQJWSA-N; NINDS_000501; HMS1921K14; HMS2092M14; HMS2096J14; HMS2235F22; Pharmakon1600-01500839; ZINC155697; HY-N0173; STR04708; ZX-AT015805; CCG-36455; CCG-37735; NSC757800; OR2776; (-)-Cinchonidine, analytical standard; AKOS016008633; API0002019; NSC-757800; SDCCGMLS-0066969.P001; IDI1_000501; NCGC00178057-01; NCGC00178057-02; SMR001233254; SBI-0051617.P002; AB0019836; Cinchonan-9-ol, (8-alpha,9R)- (9CI); CS-0007887; ST24030253; V0360; AB00052182_03; Q412713; SR-05000001575-1; SR-05000001575-6; SR-05000001575-7; SR-05000001575-8; BRD-K17661460-001-03-2; BRD-K17661460-001-04-0; BRD-K39079086-001-05-0; BRD-K39079086-001-07-6; Cinchonidine, purum, >=98.0% (dried material, NT); (R)-4-quinolyl-[(2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol; (1R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (R)-quinolin-4-yl((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (2S,4S,8R,alphaR)-alpha-(4-Quinolyl)-8-vinyl-1-azabicyclo[2.2.2]octane-2-methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol; CINCHONIDINE; cinchonine; Cinchonan-9-ol; 118-10-5; alpha-Quinidine; 485-71-2; GNF-PF-5411; MLS002637808; NSC5364; .alpha.-Quinidine; NSC 5364; {5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}(quinolin-4-yl)methanol; Cinchonan-9-ol, (8.alpha.,9R)-; quinolin-4-yl(5-vinylquinuclidin-2-yl)methanol; Cinchonan-9-ol, (9S)-; (8alpha,9R)Cinchonan-9-ol; (8-alpha,9R)-Cinchonan-9-ol; EINECS 207-622-3; SMR001488502; AI3-15317; 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; (+)-Quinolin-4-yl(5-vinylquinuclidin-2-yl)methanol; 2-Quinuclidinemethanol, .alpha.-4-quinolyl-5-vinyl-; NSC6176; (8.alpha.,9R)-Cinchonan-9-ol; Cinchonan-9-ol, (8alpha,9R)-; a-quinidine; Cinchonan-9-ol, (8a alpha,9R)-; alpha -quinidine; nchem.180-comp1b; Cinchonan-9-ol,9R)-; MLS006011421; CHEMBL15134; SCHEMBL732494; (1S)-Quinolin-4-yl((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (+)-Cinchonine; D-Cinchonine; (8alpha ,9R)-Cinchonan-9-ol; KMPWYEUPVWOPIM-UHFFFAOYSA-N; Cinchonan-9-ol, (8alpha 9R)-; HMS3369H22; HMS3372L22; (8a,9R)-Cinchonan-9-ol, 9CI; BCP18343; Cinchonan-9-ol, (8-alpha,9R)-; Cinchonan-9-ol, (8alpha ,9R)-; KS-000007WK; NSC-5364; ZX-AT020747; BBL012269; SBB006514; STL163586; AKOS000118852; AKOS022060412; CCG-245136; MCULE-3323633075; OR28810; TRA0051653; NCGC00094864-01; NCGC00094864-02; NCGC00094864-03; NCGC00094864-04; 4CN-0598; LS-53759; SC-04769; VS-03255; DB-041389; FT-0627743; FT-0658646; AB00973495-02; WLN: T66 BNJ EYQ- DT66 A B CNTJ A1U1; F0001-1271; Z256709172; (1S)((4S,2R,5R)-5-vinylquinuclidin-2-yl)-4-quinolylmethan-1-ol; (Quinoline-4-yl)(5-vinyl-1-azabicyclo[2.2.2]octane-2-yl)methanol; 1042167-24-7; 1071759-34-6; CINCHONIDINE; 485-71-2; 9-epi-Cinchonidine; SCHEMBL12268394; s2282; AKOS015965553; AC-7632; CCG-208464; NCGC00346589-02; SW219716-1; C11379; (alphaR,2S)-alpha-(4-Quinolyl)-5beta-vinyl-2alpha-quinuclidinemethanol; CINCHONIDINE; 485-71-2; Cambridge id 5152400; Oprea1_766075; CBDivE_006319; CHEMBL611480; SCHEMBL4971015; Epicinchonine, analytical standard; (R)-alpha-(5-Vinylquinuclidine-2-yl)quinoline-4-methanol; CINCHONIDINE; Cinchonan-9-ol, (8.alpha.,9R)-; .alpha.-Quinidine; NSC 5364; 485-71-2; (8.alpha.,9R)-Cinchonan-9-ol; 2-Quinuclidinemethanol, .alpha.-4-quinolyl-5-vinyl-; SCHEMBL2574722; SCHEMBL12200285; KMPWYEUPVWOPIM-BDHCGPDFSA-N; AB1011155; (R)-alpha-[(2S)-8-Vinylquinuclidine-2-yl]-4-quinolinemethanol; CINCHONIDINE; 485-71-2; CHEMBL518804; SCHEMBL12707405; ZINC3874030; BP-12999; CINCHONIDINE; 485-71-2; CINCHONIDINE; 485-71-2; SCHEMBL12576192; KMPWYEUPVWOPIM-PSWNHGHYSA-; AKOS015955679; InChI=1/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14?,18?,19-/m0/s1; CINCHONIDINE; cinchonine; 485-71-2; 118-10-5; AK-74160; CINCHONIDINE; NSC-6176; CHEMBL1590546; (3S,8S,9R)-Cinchonan-9-ol; 485-71-2; ZINC5817037; NCGC00013067; CINCHONIDINE; Epicinchonine; cinchonine; 9-Epi-cinchonine; UNII-35VE0JQR6N; 485-70-1; 35VE0JQR6N; 9-Epicinchonine; CINCHONIDINE; SR-05000001576; Cinchonan-9-ol, (9R); epi-cinchonine; 118-10-5; Spectrum_000061; Spectrum2_000594; Spectrum3_000633; Spectrum4_000823; Spectrum5_001566; BSPBio_002226; KBioGR_001365; KBioSS_000461; DivK1c_000237; SPECTRUM1500841; SPBio_000468; (R)-quinolin-4-yl((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol; SCHEMBL4575680; SCHEMBL13587301; CHEBI:92258; HMS500L19; KBio1_000237; KBio2_000461; KBio2_003029; KBio2_005597; KBio3_001726; NINDS_000237; HMS1921K16; HMS2092M16; Pharmakon1600-01500841; ZINC404802; 485-71-2; CCG-39753; NSC757801; NSC-757801; SDCCGMLS-0066951.P001; IDI1_000237; NCGC00178751-01; AS-52656; SBI-0051618.P002; AB01563191_01; SR-05000001576-1; SR-05000001576-2; BRD-K14693417-001-03-2; BRD-K18476269-001-02-9; Q27164023; CINCHONIDINE; CHEMBL2079612; SCHEMBL12589117; (S)-alpha-[(2R)-8-Vinylquinuclidine-2-yl]-4-quinolinemethanol; AI3-15317
(-)-Epigallocatechin gallate 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Epigallocatechin gallate; CCRIS 3729
(-)-Fenchone (1R,4S)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one; EINECS 232-107-5; ( -)-Fenchone; (-)-1,3,3-Trimethyl-2-norbornanone; (1R)-(-)-Fenchone; (1R,4S)-(-)-Fenchone; (1R,4S)-fenchan-2-one; (1R,4S)-fenchone; 232-107-5; 7787-20-4; fenchone, (1R)-isomer; l-alpha-Fenchone; L-Fenchone; (-)-Fenchone; 1,3,3-Trimethylnorbornan-2-one; UNII-K6G5Y2Y3Q2; (1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one; EINECS 232-107-5; K6G5Y2Y3Q2; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1R,4S)-; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1theta)-; Fenchon [German]; Bicyclo[2.2.1]heptan-2-one, 1,3,3-trimethyl-, (1R,4S)-; (1R)-fenchone; (1R,4S)-(+)-fenchone; laevo-fenchone; CCRIS 8093; 3,3-Dimethyl-8,9-dinorbornan-2-one; BRN 1861492; AI3-00736; (+-)-Fenchone; Fenchone, (-)-; L-Fenchone, >=98%; (1S)-1,3,3-Trimethylbicyclo(2.2.1)heptan-2-one; SCHEMBL527930; CHEBI:36612; DTXSID30884431; ZINC967570; (-)-Fenchone, analytical standard; (1R)-(-)-Fenchone, >=98%; LMPR0102120031; NE11297; LS-188410; FT-0627597; 2-07-00-00093 (Beilstein Handbook Reference); Q27116898; UNII-4Q6W8568TG component LHXDLQBQYFFVNW-OIBJUYFYSA-N; 126-21-6; Fenchone, (-)-; EINECS 232-107-5
(-)-Flutriafol (alphaR)-alpha-(2-Fluorophenyl)-alpha-(4-fluorophenyl)-1H-1,2,4-triazole-1-ethanol; Flutriafol, (-)-; UNII-SYO85A897P